April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Are the cases rising or falling in the countries with the most vaccinated? May 29, 2021
- Physical activity at work: how to stay healthy in daily routine? Mar 26, 2020
- Nutritionists told me how the rejection of salt affects the process of weight loss Jul 1, 2020
- Covid and school, Bassetti: “Thanks to the vaccine it will circulate less” Sep 14, 2021
- Experts Recommend Sleep Hygiene for Better Rest | Video May 27, 2021
- New restrictions in Israel to stop the spread of the Corona virus Aug 11, 2021
- Five good reasons to have tuna May 19, 2020
Maxie Eckert
Today at 11:34 AM
.
